California Public Employees Retirement System’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-197
Closed -$7K 3241
2018
Q4
$7K Hold
197
﹤0.01% 3237
2018
Q3
$15K Hold
197
﹤0.01% 3271
2018
Q2
$15K Hold
197
﹤0.01% 3274
2018
Q1
$17K Hold
197
﹤0.01% 3267
2017
Q4
$147K Hold
197
﹤0.01% 3072
2017
Q3
$57K Hold
197
﹤0.01% 3227
2017
Q2
$50K Hold
197
﹤0.01% 3286
2017
Q1
$65K Hold
197
﹤0.01% 3266
2016
Q4
$118K Hold
197
﹤0.01% 3201
2016
Q3
$223K Hold
197
﹤0.01% 3055
2016
Q2
$216K Hold
197
﹤0.01% 3110
2016
Q1
$253K Hold
197
﹤0.01% 3046
2015
Q4
$484K Hold
197
﹤0.01% 2795
2015
Q3
$217K Hold
197
﹤0.01% 3181
2015
Q2
$198K Hold
197
﹤0.01% 3289
2015
Q1
$608K Hold
197
﹤0.01% 2891
2014
Q4
$608K Hold
197
﹤0.01% 2891
2014
Q3
$571K Hold
197
﹤0.01% 2885
2014
Q2
$749K Buy
+197
New +$742K ﹤0.01% 2744

Other funds holding NBSE

California Public Employees Retirement System's NBSE Position: Q1 2019 in Review

California Public Employees Retirement System sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2019, closing a stake of 197 shares — an estimated $7K sold.

California Public Employees Retirement System first reported a position in NBSE in Q2 2014 and held it in 19 quarters. The position peaked at $749K in Q2 2014. 15 funds tracked by Wall St. Rank hold NBSE as of Q1 2019.

  • California Public Employees Retirement System reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • California Public Employees Retirement System sold 197 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $7K.
  • California Public Employees Retirement System first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and held it in 19 quarters.
  • California Public Employees Retirement System's NeuBase Therapeutics, Inc. Common Stock position peaked at $749K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2019.

Based on California Public Employees Retirement System's 13F filing for Q1 2019, filed 3 May 2019.